Diffuse Systemic Sclerosis

Common Name(s)

Diffuse Systemic Sclerosis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Diffuse Systemic Sclerosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Diffuse Systemic Sclerosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Diffuse Systemic Sclerosis" returned 60 free, full-text research articles on human participants. First 3 results:

Diffuse systemic sclerosis with bullous lesions without systemic manifestations.
 

Author(s): Paula Renaux Wanderley Caratta Macedo, Amanda Nascimento Cavalleiro de Macedo Mota, Alexandre Carlos Gripp, Maria de Fatima GuimarĂ£es Scotelaro Alves, Evandro Mendes Klumb

Journal: An Bras Dermatol. ;88(6 Suppl 1):78-81.

 

Here, we describe an atypical case of systemic sclerosis in its diffuse cutaneous form with acute and rapid progression of the cutaneous condition, without any systemic manifestations and the infrequent formation of bullae, showing the importance of diagnosis and early treatment in ...

Last Updated: 18 Dec 2013

Go To URL
Treatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial.
 

Author(s): N P Quillinan, D McIntosh, J Vernes, S Haq, C P Denton

Journal: Ann. Rheum. Dis.. 2014 Jan;73(1):56-61.

 

The primary objective of the study was to explore safety and tolerability of hyperimmune caprine serum (AIMSPRO) in established diffuse cutaneous systemic sclerosis (SSc). Secondary objectives included assessment of potential efficacy and biological activity and exploration of candidate biomarkers.

Last Updated: 5 Dec 2013

Go To URL
Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial.
 

Author(s): Emily W Hung, Maureen D Mayes, Roozbeh Sharif, Shervin Assassi, Victor I Machicao, Chitra Hosing, E William St Clair, Daniel E Furst, Dinesh Khanna, Stephen Forman, Shin Mineishi, Kristine Phillips, James R Seibold, Christopher Bredeson, Mary Ellen Csuka, Richard A Nash, Mark H Wener, Robert Simms, Karen Ballen, Sharon Leclercq, Jan Storek, Ellen Goldmuntz, Beverly Welch, Lynette Keyes-Elstein, Sharon Castina, Leslie J Crofford, Peter Mcsweeney, Keith M Sullivan

Journal: J. Rheumatol.. 2013 Apr;40(4):455-60.

 

To describe the prevalence and clinical correlates of endoscopic gastric antral vascular ectasia (GAVE; "watermelon stomach") in early diffuse systemic sclerosis (SSc).

Last Updated: 2 Apr 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Diffuse Systemic Sclerosis" returned 1 free, full-text review articles on human participants. First 3 results:

Treatment of early diffuse systemic sclerosis skin disease.
 

Author(s): Tracy M Frech, Victoria K Shanmugam, Ami A Shah, Shervin Assassi, Jessica K Gordon, Faye N Hant, Monique E Hinchcliff, Virginia Steen, Dinesh Khanna, Cristiane Kayser, Robyn T Domsic

Journal: Clin. Exp. Rheumatol.. ;31(2 Suppl 76):166-71.

 

Diffuse systemic sclerosis carries a high morbidity and mortality. The Prospective Registry of Early Systemic Sclerosis (PRESS), a multicentre incident cohort study of patients with early diffuse cutaneous systemic sclerosis, has the goal of advancing the understanding of disease ...

Last Updated: 5 Aug 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

IL1-TRAP, Rilonacept, in Systemic Sclerosis
 

Status: Recruiting

Condition Summary: Scleroderma; Systemic Sclerosis; Diffuse Scleroderma; Diffuse Systemic Sclerosis

 

Last Updated: 15 Jul 2014

Go to URL
Serial Night Time Position Splint on Systemic Sclerosis
 

Status: Recruiting

Condition Summary: Diffuse Systemic Sclerosis

 

Last Updated: 27 Apr 2012

Go to URL
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
 

Status: Not yet recruiting

Condition Summary: Diffuse Cutaneous Systemic Sclerosis

 

Last Updated: 9 Jun 2014

Go to URL